Although the clinical trial evidence for selpercatinib is highly uncertain, the independent appraisal committee concluded that it could be cost effective if more data showing people live longer with treatment becomes available from an ongoing trial.
You can consent to the use of such technologies by closing this notice.
Customise your preferences for any tracking technology
The following allows you to customize your consent preferences for any tracking technology used
to help us achieve the features and activites described below. To learn more about how these trackers help us